News | Robotic Systems | May 28, 2020

Hoag Performs First Robotic Carotid Artery Stenting on West Coast

Robotic surgery makes carotid stent placement safer and more precise 

Christopher Baker, M.D., and his team perpare to perform their first robotically navigated carotid artery stenting procedure at Hoag Memorial Hospital Presbyterian. The Corindus Corpath robotic system can be seen over the patient on the table.

Christopher Baker, M.D., and his team perpare to perform their first robotically navigated carotid artery stenting procedure at Hoag Memorial Hospital Presbyterian. The Corindus Corpath robotic system can be seen over the patient on the table.


May 28, 2020 — Hoag Memorial Hospital Presbyterian recently became the first hospital on the West Coast to perform an innovative robotic interventional procedure to stent a blockage in the carotid artery and improving blood flow to the brain. 

Christopher Baker, M.D., performs a robotically navigated carotid stenting procedure at  Hoag Memorial Hospital Presbyterian using a Corindus Corpath robotic system.Christopher Baker, M.D., director of interventional neuroradiology at the Pickup Family Neurosciences Institute at Hoag, implanted the stent using a new robotic tool, the CorPath GRX from Corindus, a Siemens Healthineers company. The robot helps physicians guide a wire, stent and balloon through a small incision in the patient’s arm or leg, and up into the patient’s neck artery to place the stent precisely at the site of blockage. This exact placement of the stent also allows less exposure to radiation for both the patient and the physician.

“CorPath is remarkable because I am able to perform a high precision, complex surgery while not being next to the patient,” Baker said. “The use of this technology means a safer, more precise surgery for the patient.”  

Thanks to donor support, Hoag’s Pickup Family Neurosciences Institute is the first site on the West Coast to perform robotic-assisted carotid stenting. Currently, robots are only FDA cleared for use in certain general surgery procedures and in peripheral vascular and interventional cardiology procedures. Baker said the tool will likely also prove invaluable in neuro-endovascular procedures. “Carotid stenting has been around for many years, but the really exciting part is the new ability to improve patient safety through precise control of the micro-tools we use in the arteries supplying the patient’s brain.”
 
As a founding member of Orange County’s designated Comprehensive Stroke Receiving Centers, Hoag’s Neurosciences team helped pioneer many of the advanced processes and specialized methods to optimize outcomes for stroke patients including prevention and reversal of acute stroke.
 
Hoag has also been designated a Center of Excellence in Robotic Surgery (COERS) by the Surgical Review Corp., which recognizes hospitals and surgeons who demonstrate an exceptional commitment and ability to consistently deliver safe, effective, evidence-based care through robotic surgery. 
 
“We are excited to be one of the first to offer this innovative robotic tool to help treat patients with significant carotid artery stenosis,” Baker said. “One cannot overstate how precision robotic-assisted tools improve outcomes and speed recovery for patients undergoing complex, very delicate surgeries and help us save more lives.”     

 


Related Content

News | Cath Lab

May 16, 2023 — Royal Philips, a global leader in health technology, announced late-breaking data from the DCR4Contrast ...

Home May 16, 2023
Home
News | Cath Lab

March 14, 2023 — Royal Philips, a global leader in health technology, and the Gibraltar Health Authority, announced they ...

Home March 14, 2023
Home
News | Cath Lab

March 1, 2023 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...

Home March 01, 2023
Home
News | Cath Lab

May 31, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, announced that the company has received ...

Home May 31, 2022
Home
News | Cath Lab

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

Home May 26, 2022
Home
News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
Subscribe Now